State Board of Administration of Florida Retirement System lifted its position in Quanterix Co. (NASDAQ:QTRX – Get Rating) by 82.8% during the second quarter, HoldingsChannel.com reports. The fund owned 23,401 shares of the company’s stock after acquiring an additional 10,600 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Quanterix were worth $379,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. Royce & Associates LP boosted its stake in shares of Quanterix by 8.3% in the second quarter. Royce & Associates LP now owns 250,748 shares of the company’s stock worth $4,060,000 after acquiring an additional 19,200 shares during the last quarter. Candriam S.C.A. boosted its stake in Quanterix by 20.0% during the second quarter. Candriam S.C.A. now owns 90,000 shares of the company’s stock worth $1,457,000 after buying an additional 15,000 shares during the last quarter. SG Americas Securities LLC acquired a new position in Quanterix during the second quarter worth $181,000. Versor Investments LP acquired a new position in Quanterix during the second quarter worth $624,000. Finally, Assenagon Asset Management S.A. boosted its stake in Quanterix by 302.8% during the second quarter. Assenagon Asset Management S.A. now owns 163,800 shares of the company’s stock worth $2,652,000 after buying an additional 123,139 shares during the last quarter. 91.85% of the stock is owned by institutional investors and hedge funds.
Quanterix Stock Up 4.9 %
NASDAQ:QTRX opened at $11.73 on Monday. Quanterix Co. has a 52 week low of $6.31 and a 52 week high of $47.26. The company has a market capitalization of $434.66 million, a P/E ratio of -4.41 and a beta of 1.32. The stock’s fifty day moving average is $10.11 and its two-hundred day moving average is $13.47.
Analyst Ratings Changes
Quanterix Company Profile
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.
- Get a free copy of the StockNews.com research report on Quanterix (QTRX)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.